Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ligand Pharma (DE:LGDN)
FRANKFURT:LGDN
Ligand Pharma (LGDN) Ownership - Who Owns Ligand Pharma?
1 Followers
Ligand Pharma (LGDN) Ownership Overview
0.00% Insiders
0.00% Mutual Funds
23.01% Other Institutional Investors
76.99% Public Companies and
Individual Investors
The ownership structure of Ligand Pharma (DE:LGDN) stock is a mix of institutional, retail and individual investors. Approximately 23.01% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 76.99% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| May 17, 2024 | Nancy Ryan Gray Director | Sold | $77709 |
| May 17, 2024 | Sold | $1146657 | |
| May 15, 2024 | Matthew Korenberg President & Chief Operating | Sold | $1495692 |
| May 13, 2024 | Andrew Reardon Clo & | Sold | $830400 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | Bought | $355046 | |
| Mar 31, 2024 | Sold | $1105564 | |
| Mar 31, 2024 | Bought | $3901858 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 22,282 | Insider | ― | 1,760,278 | |
| 28,820 | Insider | ― | 2,276,780 | |
| 23,825 | Insider | ― | 1,882,175 | |
| 133,447 | Insider | ― | 10,542,313 | |
| 42,523 | Insider | ― | 3,359,317 | |
| 3,291 | Insider | ― | 259,989 | |
| 28,263 | Insider | ― | 2,232,777 | |
| 120,160 | Insider | ― | 9,492,640 | |
| 417,695 | Insider | ― | 32,997,905 | |
| 162,187 | Insider | ― | 12,812,773 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 47,202 | Institution | ― | 4,048,327 | |
| 16,740 | Institution | ― | 1,435,723 | |
| 81,786 | Institution | ― | 7,014,458 | |
| 511 | Institution | ― | 43,826 | |
| 44,444 | Institution | ― | 3,811,784 | |
| 1,297 | Institution | ― | 111,239 | |
| 958 | Institution | ― | 82,164 | |
| 3,994 | Institution | ― | 342,549 | |
| 24,346 | Institution | ― | 2,088,059 | |
| 6,482 | Institution | ― | 555,935 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Ligand Pharma (DE:LGDN)?
According to the latest TipRanks data, approximately 23.01% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 76.99% is held by retail investors.
What percentage of Ligand Pharma (DE:LGDN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 23.01% of Ligand Pharma (DE:LGDN) stock is held by institutional investors.
What percentage of Ligand Pharma (DE:LGDN) stock is held by retail investors?
According to the latest TipRanks data, approximately 76.99% of Ligand Pharma (DE:LGDN) stock is held by retail investors.
Who owns the most shares of Ligand Pharma (DE:LGDN)?
Nishan Desilva owns the most shares of Ligand Pharma (DE:LGDN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.